APUS — Apimeds Pharmaceuticals US Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareMicro CapValue Trap

Annual balance sheet for Apimeds Pharmaceuticals US, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS/A	PROSPECTUS/A	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	0.171	0.006	0.41	0.003	3.64
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.172	0.006	0.422	0.013	14
Net Property, Plant And Equipment	—	—	—	—	0.239
Long Term Investments
Other Long Term Assets
Total Assets	0.172	0.006	0.422	0.013	164
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.011	0.32	0.123	1.02	10.7
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	0.411	0.72	0.39	1.37	10.8
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-0.238	-0.714	0.032	-1.36	153
Total Liabilities & Shareholders' Equity	0.172	0.006	0.422	0.013	164
Total Common Shares Outstanding